Lipigon Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Stefan Nilsson
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 8.4yrs |
CEO ownership | 1.4% |
Management average tenure | no data |
Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO
Stefan Nilsson (45 yo)
8.4yrs
Tenure
Dr. Stefan K. Nilsson serves as the Chief Executive Officer of Lipigon Pharmaceuticals AB since 2016. Dr. Nilsson is an entrepreneur and Co-Founder of Lipigon. Dr. Nilsson has been central in all Lipigon’s...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Business Development Manager & Chairman | 12.4yrs | no data | 0.27% SEK 8.8k | |
Independent Director | 3.1yrs | no data | 0.13% SEK 4.2k | |
Independent Director | 1.4yrs | no data | 0.024% SEK 766.0 | |
Director | 3.4yrs | no data | 0.16% SEK 5.1k | |
Scientific Advisor | no data | no data | no data | |
Scientific Advisor | no data | no data | no data | |
Scientific Advisor | no data | no data | no data | |
Scientific Advisor | no data | no data | no data | |
Scientific Advisor | no data | no data | no data | |
Independent Director | 2.4yrs | no data | 0.59% SEK 19.1k |
3.1yrs
Average Tenure
61yo
Average Age
Experienced Board: 9RP's board of directors are considered experienced (3.1 years average tenure).